See more : Federal Home Loan Mortgage Corporation (FMCCK) Income Statement Analysis – Financial Results
Complete financial analysis of DocMorris AG (DOCM.SW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DocMorris AG, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Euro Manganese Inc. (EUMNF) Income Statement Analysis – Financial Results
- Wineco Productions, Inc. (WNCP) Income Statement Analysis – Financial Results
- AXA SA (AXA.DE) Income Statement Analysis – Financial Results
- CGS International, Inc. (CGSI) Income Statement Analysis – Financial Results
- Sure Ventures Plc (SURE.L) Income Statement Analysis – Financial Results
DocMorris AG (DOCM.SW)
About DocMorris AG
DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products, as well as medicines management services. It also operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals under the Zur Rose, PromoFarma, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 969.46M | 1.61B | 1.73B | 1.48B | 1.36B | 1.21B | 982.92M | 879.54M | 834.42M | 915.55M | 910.61M | 523.31M | 487.19M | 488.27M |
| Cost of Revenue | 766.11M | 1.36B | 1.47B | 1.24B | 1.15B | 1.02B | 836.34M | 747.61M | 708.73M | 775.87M | 772.10M | 448.09M | 415.72M | 416.05M |
| Gross Profit | 203.35M | 245.63M | 260.05M | 241.33M | 208.65M | 191.21M | 146.58M | 131.93M | 125.69M | 139.68M | 138.51M | 75.21M | 71.47M | 72.22M |
| Gross Profit Ratio | 20.98% | 15.27% | 15.06% | 16.34% | 15.39% | 15.84% | 14.91% | 15.00% | 15.06% | 15.26% | 15.21% | 14.37% | 14.67% | 14.79% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 25.53M | 59.18M | 52.89M | 50.88M | 34.89M | 24.91M | 27.44M | 21.50M | 18.88M | 21.44M | 24.27M | 14.90M | 11.90M | 11.90M |
| Selling & Marketing | 96.57M | 106.21M | 173.39M | 109.74M | 53.21M | 74.40M | 60.22M | 44.87M | 36.29M | 41.83M | 48.06M | 24.29M | 23.47M | 22.14M |
| SG&A | 122.10M | 165.39M | 226.28M | 160.62M | 88.10M | 99.31M | 87.65M | 66.37M | 55.16M | 63.26M | 72.33M | 39.19M | 35.37M | 34.03M |
| Other Expenses | 81.25M | 663.00K | 626.00K | 519.00K | 437.00K | 452.00K | 441.00K | 435.00K | 447.00K | 469.00K | 458.00K | 424.00K | 583.00K | 602.00K |
| Operating Expenses | 203.35M | 404.58M | 457.27M | 359.49M | 273.19M | 223.06M | 173.61M | 139.45M | 117.70M | 131.95M | 144.71M | 72.99M | 67.32M | 65.22M |
| Cost & Expenses | 1.05B | 1.77B | 1.92B | 1.60B | 1.42B | 1.24B | 1.01B | 887.06M | 826.43M | 907.82M | 916.81M | 521.08M | 483.04M | 481.27M |
| Interest Income | 2.22M | 592.00K | 533.00K | 1.16M | 54.00K | 239.00K | 12.00K | 36.00K | 165.00K | 63.00K | 122.00K | 144.00K | 162.00K | 145.00K |
| Interest Expense | 19.14M | 17.73M | 16.19M | 14.73M | 5.28M | 1.70M | 2.30M | 2.48M | 2.47M | 2.37M | 2.47M | 1.08M | 1.15M | 1.25M |
| Depreciation & Amortization | 43.44M | 39.64M | 49.86M | 38.04M | 30.57M | 18.55M | 11.51M | 8.65M | 7.36M | 9.13M | 7.79M | 4.76M | 4.75M | 6.57M |
| EBITDA | -54.57M | -109.79M | -159.36M | -76.13M | -13.67M | -17.99M | -22.42M | -1.02M | 13.87M | 16.02M | -4.02M | 12.02M | 9.94M | 12.89M |
| EBITDA Ratio | -5.63% | -6.60% | -9.23% | -5.36% | -2.31% | -1.36% | -1.05% | 0.08% | 1.51% | 1.75% | 0.17% | -0.75% | 2.04% | 2.68% |
| Operating Income | -75.83M | -168.82M | -210.48M | -117.63M | -45.71M | -31.40M | -21.19M | -7.09M | 8.44M | 8.21M | -11.26M | 7.52M | 5.19M | 7.43M |
| Operating Income Ratio | -7.82% | -10.50% | -12.19% | -7.96% | -3.37% | -2.60% | -2.16% | -0.81% | 1.01% | 0.90% | -1.24% | 1.44% | 1.06% | 1.52% |
| Total Other Income/Expenses | -42.82M | -30.56M | -29.15M | -15.58M | -4.41M | -4.40M | -15.31M | -5.63M | -4.40M | -3.69M | -3.01M | -952.00K | -931.00K | -2.36M |
| Income Before Tax | -118.66M | -169.87M | -226.68M | -133.21M | -50.11M | -38.55M | -36.51M | -12.72M | 4.04M | 4.52M | -14.28M | 6.57M | 4.07M | 5.07M |
| Income Before Tax Ratio | -12.24% | -10.56% | -13.13% | -9.02% | -3.70% | -3.19% | -3.71% | -1.45% | 0.48% | 0.49% | -1.57% | 1.26% | 0.84% | 1.04% |
| Income Tax Expense | -1.09M | 1.25M | -949.00K | 2.44M | 2.27M | 553.00K | -241.00K | 53.00K | 598.00K | -2.64M | 1.19M | 415.00K | -4.60M | 1.15M |
| Net Income | 82.28M | -171.12M | -225.74M | -135.70M | -52.36M | -38.97M | -36.24M | -12.77M | 3.45M | 7.15M | -15.46M | 6.16M | 8.67M | 3.92M |
| Net Income Ratio | 8.49% | -10.64% | -13.07% | -9.19% | -3.86% | -3.23% | -3.69% | -1.45% | 0.41% | 0.78% | -1.70% | 1.18% | 1.78% | 0.80% |
| EPS | 7.05 | -15.88 | -23.40 | -14.95 | -6.04 | -6.14 | -6.94 | -2.82 | 1.01 | 2.11 | -4.57 | 1.92 | 2.72 | 0.86 |
| EPS Diluted | 7.05 | -15.88 | -23.40 | -14.95 | -6.04 | -6.14 | -6.94 | -2.82 | 1.01 | 2.11 | -4.57 | 1.92 | 2.72 | 0.86 |
| Weighted Avg Shares Out | 11.67M | 10.78M | 9.65M | 9.08M | 8.66M | 6.35M | 5.22M | 4.54M | 3.39M | 3.38M | 3.39M | 3.19M | 3.19M | 4.53M |
| Weighted Avg Shares Out (Dil) | 11.67M | 10.78M | 9.65M | 9.08M | 8.66M | 6.35M | 5.22M | 4.54M | 3.39M | 3.38M | 3.39M | 3.19M | 3.19M | 4.53M |
Source: https://incomestatements.info
Category: Stock Reports